Bingchun Yan

Dr. Bingchun Yan


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2020 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
BYBingchun Yan
Bingchun Yan
JCJianwen Cao
Jianwen Cao
JLJiajia Liu
Jiajia Liu
YGYunhao Gu
Yunhao Gu
ZXZhuobin Xu
Zhuobin Xu
LGLizeng Gao
Lizeng Gao

25 June 2023 in Phytomedicine
Verified
Journal Article
Closed access
YYYue Yuan
Yue Yuan
PSPeng Sheng
Peng Sheng
BMBo Ma
Bo Ma
BXBingjie Xue
Bingjie Xue
MSMengmeng Shen
Mengmeng Shen
YJYunyao Jiang
Yunyao Jiang

29 December 2018 in Journal of Neuropathology & Experimental Neurology
Verified
Journal Article
Closed access
PDF file
BYBingchun Yan
Bingchun Yan
JWJie Wang
Jie Wang
YRYanggang Rui
Yanggang Rui
JCJianwen Cao
Jianwen Cao
PXPei Xu
Pei Xu
PSPeiqing Su
Peiqing Su
Gabapentin (GBP), an analgesic, adjunct antiepileptic, and migraine prophylactic drug, reduces neuronal injury induced by cerebral ischemia reperfusion (IR). However, the underlying biological molecular mechanism of GBP neuroprotection is not clear. In this study, we confirmed that dose-dependent (75 and 150 mg/kg) GBP treatment could significantly reduce IR-induced neuronal death. IR-induced neuronal death was inhibited by pretreatment with 150 mg/kg GBP in a middle cerebral artery occlusion rat model. In addition, 150 mg/kg GBP treatment remarkably promoted the levels of antioxidants and reduced the autophagy of neurons in the infarct penumbra. Moreover, the phosphoinositide-3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) signaling pathway was activated by pretreatment with 150 mg/kg GBP, as detected by Western blot analyses. In vitro, pretreatment of PC12 cells with 450 µM GBP significantly reduced cell death induced by oxygen-glucose deprivation, increased antioxidant function, and reduced the levels of autophagy and reactive oxygen species via activation of the PI3K/Akt/mTOR pathway. This neuroprotection by GBP was inhibited significantly by 10 µM LY294002. In summary, dose-dependent pretreatment with GBP protected against cerebral IR injury via activation of the PI3K/Akt/mTOR pathway, which provided a neuroprotective function to inhibit oxidative stress-related neuronal autophagy.

1 July 2020 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
JCJianwen Cao
Jianwen Cao
CTCheng Tang
Cheng Tang
MGManman Gao
Manman Gao
YRYanggang Rui
Yanggang Rui
JZJie Zhang
Jie Zhang
BYBingchun Yan
Bingchun Yan

17 August 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HPHanqing Pang
Hanqing Pang
JGJia-Xiu Guo
Jia-Xiu Guo
YYYang Yang
Yang Yang
LXLi Xu
Li Xu
JWJian Wang
Jian Wang
LLLiang Liu
Liang Liu

12 September 2018 in Frontiers in Neurology
Verified
Journal Article
Open access
PDF file
BYBingchun Yan
Bingchun Yan
PXPei Xu
Pei Xu
MGManman Gao
Manman Gao
JWJie Wang
Jie Wang
DJDan Jiang
Dan Jiang
PSPei Qing Su
Pei Qing Su
The kainic acid (KA)-induced epilepsy experimental model is widely used to study the mechanisms underlying this disorder. Recently, the blood-brain barrier (BBB) has become an innovative alternative treatment target for epilepsy patients. KA causes neuronal injury and BBB damage in this experimental epilepsy model but the mechanisms underlying epilepsy-related neuronal injury, autophagy, and BBB damage remain unclear. Therefore, the present study investigated the relationships among neuronal injury, the expressions of autophagy-related proteins, and changes in BBB-related proteins during the acute phase of epilepsy to further understand the mechanisms and pharmacotherapy of epilepsy. NeuN immunohistochemistry and Fluoro-Jade B (FJ-B) staining in the hippocampal CA3 region revealed that neuronal death induced by intraventricular injections of 10 μg/kg KA was greater than that induced by 3 μg/kg KA. In addition, there were transient increases in the levels of microtubule-associated protein light chain 3-II (LC3I/II) and Beclin-1, which are autophagy-related proteins involved in neuronal death, in this region 24 h after the administration of 10 μg/kg KA. There were also morphological changes in BBB-related cells such as astrocytes, endothelial cells (ECs), and tight junctions (TJs). More specifically, there was a significant increase in the activation of astrocytes 72 h after the administration of 10 μg/kg KA as well as continuous increases in the expressions of platelet endothelial cell adhesion molecule-1 (PECAM-1) and BBB-related TJ proteins (Zonula occludens-1 and Claudin-5) until 72 h after KA treatment. These results suggest that the overexpression of autophagy-related proteins and astrocytes and transient increases in the expressions of BBB-related TJ proteins may be closely related to autophagic neuronal injury. These findings provide a basis for the identification of novel therapeutic targets for patients with epilepsy.